Huei-Sheng Huang

5PUBLICATIONS
2CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 25, 2026
TG-interacting factor 1 mediates TNF-induced Ccl2 expression in adipocytes to promote prostate cancer progression.

|Sep 02, 2025
CUB domain-containing protein 1 signaling dysregulates gemcitabine metabolism contributing to therapeutic resistance in T24 cells.

Kun-Lin Hsieh, Kuan-Hua Huang, Ching-Ping Chang

|Mar 13, 2024
Phosphorylation of TG-interacting factor 1 at carboxyl-terminal sites in response to insulin regulates adipocyte differentiation.

Yu-Hao Chang, Yu-Hua Tseng, Ju-Ming Wang

|Mar 02, 2023
CDCP1 (CUB domain containing protein 1) is a potential urine-based biomarker in the diagnosis of low-grade urothelial carcinoma.

Chien-Liang Liu, Hung-Wen Tsai, Shu-Ling Peng

|Jul 08, 2021
Gemcitabine-induced Gli-dependent activation of hedgehog pathway resists to the treatment of urothelial carcinoma cells.

Yu-Hao Chang, Hoi-Lam Tam, Meng-Chien Lu

Pageof 1

Frequent Collaborators

3 joint publications

Yu-Hao Chang

1 joint publications

Ching-Ping Chang